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Purpose: The aim of this study was to evaluate echocardiography-based indices of myocardial function
and markers of vascular inflammation and endothelial dysfunction in the early phases of severe sepsis.
Material and Methods: Forty-five adult patients (67% women; age 51 ± 18 years; Acute Physiology and
Chronic Health Disease Classification System II score, 23 ± 7) admitted to the intensive care unit up to
24 hours after fulfilling criteria for severe sepsis or septic shock were studied. Clinical, laboratorial
(endothelin 1 [ET1], vascular cellular adhesion molecule 1), and echocardiographic data were collected
within the first 24 hours and again 72 hours and 7 days after admission.
Results: Intrahospital mortality was 33% (15 deaths). Left ventricular (LV) dysfunction (LV ejection
fraction b55%) was identified in 15 (33%) patients, whereas right ventricular (RV) dysfunction (RV
tissue Doppler peak systolic velocity [RV-Sm] b12 cm/s) was present in 14 (30%) patients. LogET1 was
increased in patients with LV dysfunction (2.3 ± 0.6 vs 1.8 ± 0.4 pg/mL; P = .01) and RV dysfunction
(2.5 ± 0.5 vs 1.8 ± 0.4 pg/mL; P b .001) and had negative correlations with LV ejection fraction (r =
−0.50; P = .002) and RV-Sm (r = −0.67; P b .001). Left ventricular end-diastolic diameter, RV-Sm, and
diastolic dysfunction were able to discriminate survivors from nonsurvivors, and the combination of
these parameters identified groups of very low and high risk.
Conclusion: Both LV and RV systolic dysfunctions are prevalent in severe sepsis, being directly
associated with markers of endothelial dysfunction. Left ventricular nondilation, RV dysfunction, and
diastolic dysfunction seem related to poor prognosis in this scenario.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.☆ Competing interests: There are no financial or nonfinancial
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Sepsis is a clinical syndrome caused by severe infection
and is characterized by a systemic inflammatory reaction
319.e10 T. Furian et al.with varying degrees of organ dysfunction [1]. Organ failure
has a cumulative effect on sepsis-related mortality, which
may reach 70% in cases with severe hypotension [2]. In this
scenario, depression of cardiac performance has been
described for more than 3 decades in severe sepsis and
septic shock, but its impact on short-term prognosis is still
debatable [3].
Parker et al [4] published a landmark article in the early
80s demonstrating that most septic shock survivors had
increased left ventricular (LV) diameters and reduced LV
ejection fraction (LVEF). Similar findings were subsequently
observed in the right ventricle of patients with septic shock,
with normalization of right ventricular (RV) function in
survivors [5]. Recent echocardiography-based data indicate
that global myocardial hypokinesia occurs in approximately
40% of adult patients with severe sepsis [6]. Several other
reports have observed similar rates of myocardial depression
in severe sepsis and/or septic shock [7-9], although few have
fully reproduced the geometric changes initially reported by
Parker et al [10,11].
The underlying mechanisms involved in the development
of myocardial dysfunction during sepsis are not entirely
known but involve circulating factors, such as tumor necrosis
factor α and interleukin 1 β, production of reactive free
radicals and oxidants, activation of toll-like receptors,
cardiomyocyte apoptosis, and endothelial dysfunction
[12,13]. In this complex physiopathologic interplay, exper-
imental data have suggested that endothelin 1 (ET-1) has a
direct inhibitory effect on myocardial contractility [14,15],
although data linking ET-1 levels and myocardial perfor-
mance indices in clinical sepsis are scarce.
In the present prospective study, we first evaluated the
early prevalence of LV and RV dysfunction using standard
echocardiography-based and tissue Doppler imaging indices
to diagnose myocardial dysfunction in patients with severe
sepsis and septic shock. Then, we investigated the relation of
echocardiographic parameters of LV and RV function to
markers of inflammation and endothelial dysfunction.
Finally, we then described the impact of myocardial
dysfunction on the intrahospital mortality.2. Methods
2.1. Patients and study design
The study included 45 consecutive adult patients
admitted to the intensive care unit at Hospital de Clínicas
de Porto Alegre within 24 hours of diagnosis of severe sepsis
or septic shock according to internationally accepted
consensus definitions [1]. Briefly, sepsis was defined
based on clinical evidence of infection and at least 2 of
the following: (1) fever (axial temperature N38°C) or
hypothermia (axial temperature b36°C); (2) tachycardia
(heart rate N90 beats per minute); (3) tachypnea (N20 breathsper minute) or PaCO2 less than 32 mm Hg; (4) leukocytosis
(N12000 cells/mm3) or leukopenia (b4000 cells/mm3), or a
ratio of greater than 10% band cells to polymorphonuclear
cells. Severe sepsis was defined as clinical signs of sepsis
associated with organ dysfunction, alterations in perfusion,
or hypotension. Septic shock was defined as sepsis with
hypotension even after initial volume expansion. Exclusion
criteria were as follows: (1) age greater than 80 years, (2)
heart failure, (3) liver failure (Child-Pugh class C), (4)
bone marrow failure (leukocytes b500/μL), or (5) immu-
nosuppression (acquired human immunodeficiency, use of
immunosuppressants, including corticosteroids [prednisone
N1 mg/kg per day], or cancer), and (6) infective endocarditis.
2.2. Study protocol
Clinical features and laboratory data of patients were
collected at admission, including Acute Physiology and
Chronic Health Disease Classification System II score,
hemoglobin and leukocytes, C-reactive protein, and serum
lactate levels. Serial transthoracic echocardiography was
performed within the first 24 hours from admission (H24)
and reassessed after 72 hours (H72) and 7 days (D7).
Informed consent was signed by all patients or guardians
before inclusion in the study. The study was approved by the
institution's research ethics committee.
2.3. Echocardiography
Transthoracic 2-dimensional echocardiography was per-
formed in the intensive care unit, using an adult transducer
(2.0-5.0 MHz), with harmonic imaging capability, and a
commercially available ultrasound system (Philips EnVisor,
Andover, Mass). Analysis was focused on parameters of
systolic and diastolic function of both left and right
ventricles, including LV diameters and LVEF, pulse wave
Doppler of mitral inflow (E wave, A wave, and E/A ratio),
tissue Doppler analysis of the lateral corner of the mitral ring
movement (early diastolic velocity [Em], late diastolic
velocity [Am], and the E/Em ratio), as well as peak systolic
velocities (Sm of the right and left ventricles). Measurements
were performed in triplicates, according to accepted
guidelines and protocols [16,17], and the mean was used
for statistical analysis.
2.4. Blood-derived markers
Quantitative determination of human ET-1 in extracted
plasma samples from septic patients was performed using
commercially available enzyme-linked immunosorbent
assay (R&D Systems, Minneapolis, Minn), according to
the manufacturer's recommendations. The limits of detection
for ET-1 were 4.2 to 117 pg/mL. Before the assay, plasma
samples underwent solvent extraction (acetone:1 N HCl:
water [40:1:5]) were lyophilized in a centrifugal evaporator
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6 (IL-6) and soluble vascular cell adhesion molecule 1
(sVCAM-1) concentrations were also quantified in plasma
samples using commercially available enzyme-linked im-
munosorbent assay (R&D Systems, Minneapolis, Minn),
according to the manufacturer's recommendations. Interleu-
kin 6 detectable levels ranged from 3 to 300 pg/mL, and
VCAM-1 detectable levels ranged from 6.25 to 200 pg/mL.
2.5. Flow-mediated dilation evaluation
Flow-mediated dilation (FMD) was assessed in the
brachial artery using a high-frequency transducer (7.5-10
MHz), according to a protocol previously described [18].
Briefly, baseline images were recorded, and brachial artery
posteroanterior diameter was measured in diastole, in 3
adjacent segments, in 3 consecutive beats. A pressure cuff
was then placed on the forearm and inflated to 230 to 250
mm Hg for 5 minutes. Brachial artery diameter was
measured again 45 to 60 seconds after sudden cuff deflation.
The mean of the 9 measurements of baseline and
posthyperemia diameters was used for statistical analysis.
Flow-mediated dilation was expressed as the relative change
(%) in brachial artery diameter during hyperemia. Therefore,
positive percentage values indicate vasodilation, whereas
negative percentage values indicate constriction.
2.6. Statistical analysis
Quantitative variables are presented as mean ± SD or
median and interquartile range; categoric variables are
expressed as absolute numbers and percentages. Variables
without normal distribution underwent logarithmic transfor-
mation. Student t test, χ2, or Fisher exact test was used for
comparisons between the groups, as appropriate. Correla-
tions between echocardiographic parameters and blood-
derived markers were assessed by Pearson or Spearman
coefficients, as appropriate. To study the behavior of
echocardiographic parameters over time, 2-way analysis of
variance for repeated measures was used using general linear
models (SAS Software 8.0, Cary, NC). Two-tailed P b .05
was considered as statistically significant.3. Results
3.1. Patients' clinical characteristics
We enrolled 45 septic patients (65% women; mean age,
51 ± 18 years; 77% of abdominal and respiratory etiology).
Mean length of stay in the intensive care unit was 8 days
(median, 6 days; 3-13 days). In 72% of patients, vasoactive
drug therapy was required, and 87% of them were on
mechanical ventilation. During hospitalization, 15 (33%)
patients died because of sepsis. The baseline characteristicsof survivors were similar to septic patients who died during
follow-up (nonsurvivors). There was a trend of survivors to
be younger (Table 1).
3.2. Left and right ventricular
echocardiography parameters
Left ventricular dysfunction was defined as LVEF less
than 55% or LV tissue Doppler peak systolic velocity (LV-
Sm) less than 12 cm/s, and RV dysfunction was defined as
RV tissue Doppler peak systolic velocity (RV-Sm) 12 cm/s or
less. Left ventricular dysfunction was detected in nearly a
third of the enrolled patients by using either LVEF (35.6%) or
LV-Sm (38.6%). Likewise, RV dysfunction detected by RV-
Sm occurred in 31.8% of patients. We observed a positive
correlation between LVEF and both LV and RV tissue
Doppler peak systolic velocities (r = 0.49, P b .01 for both;
Fig. 1). The correlation between LV and RV tissue Doppler
peak systolic velocities was also statistically significant and
positive, with a stronger correlation coefficient (Fig. 1).
In general, there were no profound cardiac structural or
functional changes as evaluated by echocardiography in this
group of patients (Table 1). In addition, LV function, as
assessed by ejection fraction or by tissue Doppler peak
systolic velocity, was similar between survivors and
nonsurvivors. On the other hand, survivors had higher LV
end-diastolic diameter and better right ventricle function as
assessed by RV-Sm. Interestingly, diastolic dysfunction was
significantly associated to prognosis is this group of patients
(lower Em values in nonsurvivors).
3.3. Blood derived markers, FMD
and echocardiography
To investigate possible mechanisms involved in the
ventricular dysfunction of severe sepsis, we evaluated the
correlation between blood-derived markers of inflammation
(sVCAM-1, IL-6, and ultra-sensitive C-reactive protein) and
endothelial dysfunction (ET-1) with echocardiographic
parameters of ventricular function and dilation. sVCAM-1,
IL-6, and ultra-sensitive C-reactive protein were not
correlated to LVEF, tissue Doppler peak systolic velocities,
or LV diameters (data not shown, all P N .2).
In contrast, LogET-1 levels were significantly increased
in patients with LV dysfunction (2.3 ± 0.6 pg/mL vs 1.8 ± 0.4
pg/mL in patients without dysfunction; P = .002) and RV
dysfunction (2.5 ± 0.5 pg/mL vs 1.8 ± 0.4 pg/mL in patients
without dysfunction; P b .001); no association to LV
diameter was observed. Interestingly, ET-1 levels were
significantly and inversely associated to both LV and RV
function in these patients (Fig. 2).
Despite lower nominal values for patients with myocardial
dysfunction, there was no statistically significant differences in
FMDvalues in patients with orwithout LVdysfunction (0.6%±
6.7% vs 2.7% ± 5.7%; P = .33), as well as with or without RV
Table 1 Clinical and echocardiographic characteristics of studied patients
All (n = 45) Survivors (n = 30) Nonsurvivors (n = 15) P
Age (y) 51 ± 18 48 ± 20 58 ± 13 .06
Male (%) 35 40 27 .38
APACHE II 23 ± 7 22 ± 7 25 ± 9 .29
Infection site (%) .36
Respiratory 24 27 20
Abdominal 33 30 53
Urinary 13 17 7
Vasopressor agents (%) 72 73 69 .52
Systolic blood pressure (mm Hg) 109 ± 19 107 ± 15 111 ± 27 .52
Heart rate (beats per minute) 108 ± 19 107 ± 19 111 ± 18 .50
CVP (cm H20) 14 ± 5 13 ± 5 14 ± 5 .57
Time since sepsis started (h) 16.2 ± 5.9 17.3 ± 6.2 14.4 ± 5.1 .17
Mechanical ventilation (%) 87 83 93 .64
Acute lung injury/ARDS (%) 33/20 33/23 33/13 .42
Blood-derived markers
Endothelin (pg/mL) 8.7 ± 5.9 8.3 ± 3.7 9.7 ± 9.3 .51
Interleukin 6 (pg/mL) 244 ± 113 229 ± 114 276 ± 109 .24
C-reactive protein (mg/L) 209 ± 125 195 ± 126 245 ± 128 .29
Echocardiographic parameters
LV end-diastolic diameter/height (cm/m) 2.8 ± 0.3 2.9 ± 0.3 2.7 ± 0.3 .04
LV end-diastolic volume (mL) 100 ± 31 107 ± 32 87 ± 22 .04
LVEF (%) 57 ± 13 57 ± 15 57 ± 10 .94
Left atrium (cm) 3.7 ± 0.5 3.8 ± 0.5 3.6 ± 0.6 .19
Right ventricle (cm) 2.4 ± 0.4 2.4 ± 0.4 2.3 ± 0.4 .84
E/A ratio 1.36 ± 1.16 1.59 ± 1.35 0.88 ± 0.33 .06
E/Em ratio 7.1 ± 3.2 6.8 ± 2.7 7.7 ± 4.1 .40
Em 12.2 ± 4.6 13.2 ± 4.7 10.1 ± 3.7 .03
LV-Sm (cm/s) 12.7 ± 2.9 12.6 ± 3.1 12.9 ± 2.8 .78
RV-Sm (cm/s) 14.0 ± 3.6 14.9 ± 3.7 12.5 ± 3.1 .04
Inferior vena cava (cm) 1.6 ± 0.6 1.7 ± 0.6 1.6 ± 0.4 .63
APACHE II indicates Acute Physiology and Chronic Health Disease Classification System II; CVP, central venous pressure; ARDS, acute respiratory
distress syndrome.
319.e12 T. Furian et al.dysfunction (0.4% ± 7.5% vs 2.8% ± 5.3%; P = .28). As
expected, LogET1 had a moderate inverse statistically
significant association to FMD (r = −0.40; P = .02).
3.4. Echocardiographic characteristics
and prognosis
Given the association of smaller LV end-diastolic
diameter, RV dysfunction, and diastolic dysfunction toFig. 1 Correlation between echocardiographic markers of ventricular f
and RV-Sm; (C) LV-Sm and RV-Sm.mortality, we evaluated cutoff values for these parameters,
based on quartiles of the distribution, to discriminate
survivors from nonsurvivors in our sample. Patients in the
highest quartiles of LV end-diastolic diameter, RV-Sm,
and Em were compared with the others. As shown in
Table 2, patients in the lower values of RV-Sm and of Em
had significant higher mortality, with a trend for those in
the lower indexed LVEDD values. In a multivariate
analysis controlling for age, the presence of at least 1unction. A, Left ventricular ejection fraction and LV-Sm; B, LVEF
Fig. 2 Correlation between markers of left (LVEF and LV-Sm) and right (RV-Sm) ventricular function and lnET-1 levels.
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mortality, and patients without any of those markers had
better prognosis.
Finally, follow-up echocardiography showed no signifi-
cant changes in LV end-diastolic diameter or RV function
over time, and LV function tended to improve as assessed by
LVEF (Fig. 3).4. Discussion
In the present prospective evaluation, we have demon-
strated that (1) severe sepsis or septic shock is associated to
early and frequent biventricular dysfunction, (2) ET-1 levels
were associated to both LV and RV dysfunction, and (3) LV
nondilation, RV systolic dysfunction, and diastolic dysfunc-
tion were associated to poor prognosis. On one hand, these
results validate the original findings about prevalence of
cardiac dysfunction described by Parker et al [4] almost 30
years ago. On the other hand, our findings suggest the
association between endothelial and ventricular dysfunction
in sepsis, and we show that the use of tissue Doppler and
evaluation of diastolic function may add to the care andTable 2 Mortality rates according to echocardiographic
parameters




No 17.6 .08 NS
Yes 42.8
S wave (RV) ≤16 cm/s
No 10 .01 NS
Yes 41.2
Em ≤15 cm/s
No 0 .02 NS
Yes 44.1
Combination of parameters
None 12.5 b.01 .004
At least 1 63.2prognosis assessment in patients with severe sepsis and
septic shock.
The elevated prevalence of depression in cardiac
performance seen in our study was not unexpected.
Although LV dysfunction definition has not been uniform
across studies, most reports have demonstrated rates of
myocardial dysfunction approaching up to 60% of patients
with septic shock [4,6]. Similarly, it has been shown that
myocardial depression in severe sepsis affects both
ventricles simultaneously and with similar pattern of
dysfunction [5]. However, although previous data were
mostly derived from invasive hemodynamic [4-6] or
conventional 2-dimensional echocardiogram studies [7-8],
we were able to demonstrate that biventricular dysfunction
can also be easily detected by tissue Doppler imaging. In
fact, echocardiography has been proposed as a comprehen-
sive yet rapid noninvasive method for cardiac assessment in
patients with hemodynamic instability [16], and our work
reinforces this concept with new data regarding tissue
Doppler imaging. In this scenario, a recent guideline
endorsed by several international echocardiography associ-
ations suggests that the interrogation of the S' wave by
pulsed tissue Doppler is a simple and reproducible
parameter to assess basal RV free wall function and should
be used in the overall evaluation of RV function [17]. In
addition, recent data in general intensive care unit patients
suggested that the addition of abnormal tissue Doppler
imaging in a model including N-terminal-pro-brain natri-
uretic peptide and sepsis increased the model's discrimina-
tive power to prognosticate in-hospital mortality [19].
Moreover, experimental data on cardiac dysfunction during
the early period following lipopolysaccharides' challenge in
rats indicate that cardiac performance alterations were
detected only by tissue Doppler imaging but not by LV
conventional echocardiographic parameters [20]. These
early changes in tissue Doppler imaging were significantly
associated with reactive oxygen species and tumor necrosis
factor α overproduction.
In our study, ET-1 was increased in patients with either
LV or RV dysfunction, and its levels were inversely
correlated to LV and RV function. Although there are strong
experimental data linking ET-1 production and blockade to
the processes that lead to cardiac dysfunction [14,15,21], few
Fig. 3 Follow-up echocardiography data for survivors and nonsurvivors. Data presented for LVED, LVEDD, LV-Sm, and RV-Sm.
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association between ET-1 circulating levels and parameters
of cardiac function. As such, our findings indicate that
endothelial dysfunction may be associated and implicated in
sepsis-induced myocardial dysfunction. The hemodynamic
changes observed in patients with severe sepsis could be
attributed to a generalized dysfunction of the cardiac and
vascular systems, rather than the usual established concept of
failure restricted to the myocardial tissue. In addition, the
absence of correlation of myocardial function parameters and
markers of inflammation (sVCAM-1 and IL-6) may be
secondary to the multiple disarrangements observed in
patients with sepsis. Several systems involved in the
complex response to sepsis might be stimulating inflamma-
tory pathways making it difficult to evaluate direct
correlations between the myocardial condition and markers
of inflammation.
Our findings also suggest that patients with LV dilation
and preserved RV and diastolic function have a better
prognosis compared with those without dilation and with
RV or diastolic dysfunction. A recent experimental study by
Zanotti et al [22] shows, in a murine model of sepsis, that
animals with LV dilation had better cardiovascular
performance and increased survival. Left ventricular
dilation might be, in fact, part of a crucial response from
the cardiovascular system to the striking hemodynamic
changes imposed during different phases of sepsis. Again,
these data taken together corroborate the original findings
proposed by Parker and et al [4]. Likewise, recent studies
suggest that diastolic dysfunction is an important compo-
nent of myocardial dysfunction in sepsis and that it may bean independent predictor of mortality [23,24]. Our study is
in agreement with those studies because diastolic dysfunc-
tion was in fact associated to prognosis. Whether systolic
and diastolic dysfunctions are separate components of
myocardial dysfunction or represent pieces of the same
process must be further assessed in future studies.
Some methodological aspects of the current protocol
deserve consideration. First, it could be considered that
pulmonary or volume status could interfere with echocar-
diographic measures and their associations to prognosis.
However, both mechanical ventilation and acute lung injury
were similar between survivors and nonsurvivors, making it
less probable that this could be a confounder in the present
study. Likewise, volume status, as inferred by interior vena
cava values, was identical in both groups. We acknowledge
that our sample size was relatively limited and some of our
findings should be interpreted as hypotheses generating,
especially regarding prognosis data. In addition, use of
transesophageal echocardiography might have enhanced the
accuracy to evaluate changes in ventricular geometry and
might have enhanced even more the associations observed
with ET-1. Finally, the cross-sectional associations between
ET-1 and echocardiography parameters do not allow cause-
effect assumptions.
In conclusion, myocardial dysfunction is a prevalent and
early phenomenon in sepsis, being directly associated to ET-
1 levels. Lack of LV dilation, as well as the presence of RV
or diastolic dysfunction, seem related to adverse prognosis in
this scenario. The evaluation of these cardiac parameters can
be noninvasively addressed by echocardiography, particu-
larly by Doppler tissue imaging.
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